Results 251 to 260 of about 484,151 (372)
A Single-center Experience of Coccidioides Meningitis in Immunocompetent Patients: Case Series and Literature Review. [PDF]
Rajmohan R+8 more
europepmc +1 more source
Comparison of the indirect fluorescent antibody test with agglutination, complement-fixation, and Coombs tests for Brucella antibody [PDF]
J M Edwards+2 more
openalex +1 more source
During a heart attack, neutrophils rapidly activate and differentiate into a specific subset characterized by high levels of MMP9, a tissue‐damaging enzyme, via the SPI1/CST7 pathway. These neutrophils form harmful net‐like structures (Neutrophil extracellular traps, NETs) that exacerbate heart injury.
Shiyu Hu+13 more
wiley +1 more source
<i>CR1</i> variants contribute to FSGS susceptibility across multiple populations. [PDF]
Skitchenko R+10 more
europepmc +1 more source
Complement fixation antibody test for human nocardiosis [PDF]
J. Zevi Shainhouse+2 more
openalex +1 more source
This study presents the NEV β‐secretase activity assay, a groundbreaking method for noninvasive evaluation of β‐secretase activity in Alzheimer's disease (AD) patients, enabling the generation of individualized β‐secretase activity profiles.
Hyoyong Kim+19 more
wiley +1 more source
The mechanical test as a supplemental decision support tool for the safe removal of an Ilizarov circular external fixator. [PDF]
Xu Y+5 more
europepmc +1 more source
Studies of Antigens for Complement Fixation and Gel Diffusion Tests in the Diagnosis of Infections Caused by Brucella ovis and Other Brucella [PDF]
Donald M. Myers+2 more
openalex +1 more source
Enhancer eccANKRD28‐manipulated MM cells have been demonstrated to facilitate drug resistance and promote MM progression by activating the key transcription factor, POU2F2. POU2F2 interacts with sequence‐specific eccANKRD28 as well as RUNX1 and RUNX2 motifs to form the protein complex, which activates the promoter of oncogenes (IRF4, JUNB, IKZF3, et al.
Binzhen Chen+12 more
wiley +1 more source